Get trade alerts

ARS Pharmaceuticals ($SPRY) Insider Trading & Smart Money Activity

ARS Pharmaceuticals, Inc. · Biotechnology · Latest filing Jun 25, 2026

ARS Pharmaceuticals, Inc. ($SPRY) has 14 insider trades and 1 analyst rating on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($67.10K), net -$67.10K.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
1
Net insider $ (12 mo)
-$67.10K
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
1

SPRY insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 2 · $67.10K 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All SPRY insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Analyst Leerink Partners Reiterates to buy PT $24 +6.7%-28.2% Read
Insider Peter Thompson Buy (Grant or award) 30K sh -24.7%-43.6% Read
Insider Laura Shawver Buy (Grant or award) 30K sh -24.7%-43.6% Read
Insider Pratik Shah Buy (Grant or award) 30K sh -24.7%-43.6% Read
Insider Phillip Schneider Buy (Grant or award) 30K sh -24.7%-43.6% Read
Insider Brent Saunders Buy (Grant or award) 30K sh -24.7%-43.6% Read
Insider L.P. Ra Capital Management Buy (Grant or award) 30K sh -24.7%-43.6% Read
Insider Saqib Islam Buy (Grant or award) 30K sh -24.7%-43.6% Read
Insider Rajeev Dadoo Buy (Grant or award) 30K sh -24.7%-43.6% Read
Insider Eric KarasChief Commercial Officer Sell (Option exercise) 25K sh +2.3%-20.7% —
Insider Eric KarasChief Commercial Officer Sell (Option exercise) 25K sh +2.3%-20.7% Read
Insider Eric KarasChief Commercial Officer Buy (Option exercise) 25K sh $37.50K +2.3%-20.7% —
Insider Eric KarasChief Commercial Officer Buy (Option exercise) 25K sh $37.50K +2.3%-20.7% Read
Insider Alexander FitzpatrickChief Legal Officer Sell (Open-market sale) 10b5-1 3.35K sh $33.55K +2.3%-20.7% —
Insider Alexander FitzpatrickChief Legal Officer Sell (Open-market sale) 10b5-1 3.35K sh $33.55K +2.3%-20.7% Read

1W / 1M / 6M = how SPRY moved from the trade or filing date.

Insider trading in SPRY: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Peter Thompson 1 — Jun 24, 2026
Laura Shawver 1 — Jun 24, 2026
Pratik Shah 1 — Jun 24, 2026
Phillip Schneider 1 — Jun 24, 2026
Brent Saunders 1 — Jun 24, 2026
L.P. Ra Capital Management 1 — Jun 24, 2026
Saqib Islam 1 — Jun 24, 2026
Rajeev Dadoo 1 — Jun 24, 2026
Eric Karas Chief Commercial Officer 4 — Jun 12, 2026
Alexander Fitzpatrick Chief Legal Officer 2 -$67.10K Jun 12, 2026

Analyst ratings on SPRY

DateFirmActionRatingPrice target1W1M6MStory
Leerink Partners Reiterates buy $24 +6.7%-28.2% Read

Frequently asked questions

Are SPRY insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 2 open-market sales worth $67.10K, a net -$67.10K.

What is the latest insider trade in SPRY?

Peter Thompson filed a buy (grant or award) of 30K sh on Jun 24, 2026.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text